Crescent Biopharma (CBIO) Current Taxes (2013 - 2015)

Crescent Biopharma (CBIO) posted quarterly Current Taxes of $20388.0 for Q1 2015, down 81.88% quarter-over-quarter from $112511.0 in Q4 2014.

Crescent Biopharma (CBIO) Current Taxes (2013 - 2015) Analysis & Trends

Crescent Biopharma (CBIO) has reported Current Taxes for 3 consecutive years, with $20388.0 the latest figure, recorded in Q1 2015.

In Q1 2015, Current Taxes changed N/A year-over-year to $20388.0; the TTM figure through Mar 2015 stood at $20388.0 (changed N/A YoY), while the FY2014 annual figure was $112511.0, up 2043.07% from the prior year.
Current Taxes fell to $20388.0 in Q1 2015 per CBIO's latest filing, from $112511.0 in the prior quarter.
Across five years, Current Taxes topped out at $136758.0 in Q2 2014 and bottomed at $5250.0 in Q4 2013.
Historically, Current Taxes has averaged $72981.4 across 3 years, with a median of $90000.0 in 2014.
On a YoY basis, Current Taxes climbed as much as 2043.07% in 2014 and fell as far as 2043.07% in 2014.
Crescent Biopharma's Current Taxes stood at $5250.0 in 2013, then surged by 2043.07% to $112511.0 in 2014, then sank by 81.88% to $20388.0 in 2015.
Business Quant data shows CBIO's Current Taxes at $20388.0 in Q1 2015, $112511.0 in Q4 2014, and $90000.0 in Q3 2014.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	49.00 Mn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	76.32 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	76.36 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Crescent Biopharma	1.10 Bn	933.02 Mn	-	-

Download Data